News Summary

• ELIOS system met the study’s co-primary effectiveness endpoints, demonstrating both statistically significant and clinically meaningful IOP reduction.
• ELIOS is an implant-free, minimally invasive glaucoma procedure that uses excimer laser technology to create microchannels in the trabecular meshwork.
• The procedure is currently under development in the United States and has not been reviewed by the U.S. Food and Drug Administration (FDA) for safety or effectiveness.